Yayın:
Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAtlı, Özlem
dc.contributor.authorERGUN, BÜLENT
dc.contributor.authorILGIN, SİNEM
dc.contributor.authorDilek Burukoğlu
dc.contributor.authorAhmet Musmul
dc.contributor.authorBaşar Sırmagül
dc.contributor.orcid0000-0001-7331-1975
dc.contributor.orcid0000-0002-3646-7935
dc.contributor.orcid0000-0003-3669-7017
dc.date.accessioned2025-11-13T10:42:39Z
dc.date.issued2016-01-01
dc.identifier.doihttps://doi.org/10.14744/anatoljcardiol.2016.6891
dc.identifier.endpage17
dc.identifier.issn2149-2263
dc.identifier.issue1
dc.identifier.openalexW2342970471
dc.identifier.startpage8
dc.identifier.urihttps://hdl.handle.net/11421/5023
dc.identifier.urihttp://doi.org/10.14744/anatoljcardiol.2016.6891
dc.identifier.volume17
dc.language.isoen
dc.relation.ispartofThe Anatolian Journal of Cardiology
dc.rightsopenAccess
dc.subjectSildenafil
dc.subjectMedicine
dc.subjectMatrix metalloproteinase
dc.subjectEverolimus
dc.subjectPulmonary hypertension
dc.subjectPharmacology
dc.subjectPulmonary artery
dc.subjectPathogenesis
dc.subjectInternal medicine
dc.subjectCardiology
dc.subject.sdg3
dc.titleMatrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5110553744
local.authorid.openalexA5053426825
local.authorid.openalexA5065693367

Dosyalar

Koleksiyonlar

Publications